CD43 anticorps (AA 226-253)
-
- Antigène Voir toutes CD43 (SPN) Anticorps
- CD43 (SPN) (Sialophorin (SPN))
-
Épitope
- AA 226-253
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CD43 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogène
- This SPN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 226-253 amino acids from the Central region of human SPN.
- Clone
- RB23613
- Isotype
- Ig Fraction
- Top Product
- Discover our top product SPN Anticorps primaire
-
-
- Indications d'application
- WB: 1:8000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- Date de péremption
- 6 months
-
- Antigène
- CD43 (SPN) (Sialophorin (SPN))
- Autre désignation
- SPN (SPN Produits)
- Synonymes
- anticorps CD43, anticorps GALGP, anticorps GPL115, anticorps LSN, anticorps A630014B01Rik, anticorps Cd43, anticorps Galgp, anticorps Ly-48, anticorps Ly48, anticorps Lsn, anticorps Lsn1, anticorps gpL115, anticorps sialophorin, anticorps SPN, anticorps Spn
- Sujet
- Sialophorin (leukosialin) is a major sialoglycoprotein on the surface of human T lymphocytes, monocytes, granulocytes, and some B lymphocytes, which appears to be important for immune function and may be part of a physiologic ligand-receptor complex involved in T-cell activation.
- Poids moléculaire
- 40322
- ID gène
- 6693
- NCBI Accession
- NP_001025459, NP_003114
- UniProt
- P16150
- Pathways
- Regulation of Leukocyte Mediated Immunity
-